Month: June 2021
Hapbee (OTC: HAPBF) Selects Accomplished Technology and Consumer Products Entrepreneur & Executive as CEO
Transformational Entrepreneur Yona Shtern to Lead Hapbee as it Advances Commercialization Phase of Business Development VANCOUVER, BC, June 2, 2021 – Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), a wellness technology […]
Skylight Health (OTC: SHGFF) Announces Award of US Clinical Trial
Skylight Health has been selected as a clinical site to enroll patients for a clinical research trial investigating ADG20, a broadly neutralizing monoclonal antibody, for use in the prevention of COVID-19 The Skylight Health Research […]
Health Canada Accepts (OTC: TBPMF) New Drug Submission for REDUVO(TM) as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 28, 2021 to its short form base shelf prospectus dated April 1, 2020 The Company approaches a […]